Biozona Weekly: Arizona biolabs; Alzheimer’s study; Clinical trials

June 5, 2015

By Matt Ellsworth

ASU to plant roots in Innovation Park
6/3/15 | The Explorer | Staff Report

Arizona State University plans to open a 50,000-square-foot facility in Oro Valley’s Innovation Park that will serve as a space for biomedical and high-tech research companies and offer office space, labs, biospecimens collection and repository and training suites.

What’s lurking in Arizona university biolabs may surprise
6/1/15 | Arizona Republic | Paul Giblin

Scientists in Biosafety Level 3 labs at Arizona’s three state universities conduct research with broad implications, leading to results that impact people locally, nationally and even globally.

Banner Alzheimer’s Institute gets $10 million for new continuing prevention research
6/1/15 | Phoenix Business Journal | Patrick O’Grady

The Banner Alzheimer’s Institute will receive $10 million for a new study that will focus on two separate therapies and how they may work on a specific gene that is considered to be present in people who have an increased risk of developing the disease.

What investing in a biomedical campus could get us
5/29/15 | Arizona Republic | Patrick Soon-Shiong (Op-ed)

Phoenix is getting a new biomedical campus, and Patrick Soon-Shiong helps explains what it will mean for the city, Arizona State University, and area residents.

Longtime Tucson Medical Center CEO Shropshire dies

5/29/15 | Arizona Daily Star | Stephanie Innes

Donald Shropshire, a community leader who became Tucson Medical Center CEO in March 1967 and oversaw the independent hospital’s growth over the next 25 years, has died at the age of 87.

ClearData lands $25 million in latest funding round
5/28/15 | Phoenix Business Journal | Hayley Ringle

ClearData Networks Inc., the Tempe-based health care cloud-computing software and service provider, has closed on $25 million to expand its sales and marketing team and continue developing its software.

$15 million poured into Tucson firm’s HIV drug work
5/27/15 | Arizona Daily Star | Staff Report

Tucson-based Calimmune Inc., an early-stage biotech drug company, has raised $15 million in investment capital to fund the company’s ongoing HIV/AIDS drug trials, advanced research, and operations.

Computer scientist’s path to beating cancer spawned a data-driven treatment approach
5/26/15 | Arizona Capitol Times | Emi Kamezaki

Marty Tenenbaum, a computer scientist and Internet entrepreneur who after being diagnosed with cancer created Cancer Commons to better deliver personalized medicine, wants to open a regional chapter of his organization in Phoenix.

Clinical trials take center stage during 2015 AZBio Expo

5/26/15 | Arizona Capitol Times | Emi Kamezaki

Medical and science professionals from around the country gathered at the Sheraton Downtown Phoenix for Arizona BioIndustry Association’s annual exposition to discuss the role clinical trials play in advancing the bioscience industry.

Phoenix Soundoff: Leaders cheer biomedical campus expansion
5/22/15 | Arizona Republic | Dustin Gardiner

Phoenix City Council members respond to their approval of a massive expansion of the Phoenix Biomedical Campus proposed by Arizona State University in partnership with billionaire Dr. Patrick Soon-Shiong.

Integrative health clinic affiliated with Weil planned here
5/20/15 | Arizona Daily Star | Stephanie Innes

A $2.5 million health clinic developed by the University of Arizona Center for Integrative Medicine is expected to open in Tucson in 2016.

ASU professor named most creative person for Ebola work
5/20/15 | KTAR | Staff Report

Arizona State University professor Charles Arntzen has been named Fast Company’s most creative person of the year for his Ebola drug research that led to a successful experimental treatment for two American doctors who contracted the disease in Africa.